Cressey & Company

Cressey & Company

Cressey & Company launched in 2008 when Bryan Cressey, a pioneer in healthcare private equity, departed GTCR to form a firm with a singular focus on middle-market healthcare services. Peter Ehrich, who had worked alongside Cressey at GTCR, co-founded the firm, bringing continuity to investor relationships and a shared thesis that fragmentation in provider services would create decades of consolidation opportunity. The firm is headquartered in Chicago with an additional office in Nashville, positioning it within two of the largest healthcare services hubs in the United States. The firm invests across the healthcare services spectrum, targeting provider services, payer services, and healthcare information technology. Stage coverage centers on growth equity and buyout transactions in companies generating between $5 million and $25 million of EBITDA. Cressey structures its investments through traditional private equity fund vehicles, closing its most recent flagship fund, Cressey & Company Fund VI, in 2018. Confirmed historical portfolio positions include behavioral health platform The MENTOR Network, dermatology practice consolidator Forefront Dermatology, and hospice provider Compassus. The geographic focus is exclusively the United States, with deep activity in fragmented, multi-site healthcare models that benefit from operational scale. The firm operates with a compact team of senior partners who maintain board-level involvement in each portfolio company, supplemented by an extended network of operating advisors drawn from healthcare C-suites. In addition to its Chicago headquarters, the Nashville office reflects the concentration of healthcare services companies in the region. Philanthropic structures or adjacent club vehicles are not publicly disclosed. In July 2019, Cressey & Company sold The MENTOR Network, a provider of home and community-based health services, to Centerbridge Partners in a transaction that marked one of the larger exits in the firm's history. Cressey's structural differentiator is the duration and depth of its general partners' domain concentration. While most healthcare private equity firms are broad generalists or sub-sector dabblers, Bryan Cressey has invested continuously in healthcare services since the 1980s, spanning cycles that have repeatedly reshaped reimbursement, regulation, and care delivery. This longitudinal view informs a deal sourcing model that relies heavily on founder relationships and executive referrals rather than broad auction processes, a posture that matters in a sector where cultural fit and regulatory nuance determine integration success.